PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)

The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA) evaluated older adult pneumococcal vaccination and was one of the largest vaccine clinical trials ever conducted. Among older adults aged ≥65 years, the trial established 13-valent pneumococcal conjugate vaccine (PCV13) efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Theilacker, Christian, Fletcher, Mark A., Jodar, Luis, Gessner, Bradford D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778913/
https://www.ncbi.nlm.nih.gov/pubmed/35056576
http://dx.doi.org/10.3390/microorganisms10010127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778913/
https://www.ncbi.nlm.nih.gov/pubmed/35056576
http://dx.doi.org/10.3390/microorganisms10010127

Ejemplares similares